|
SALUTE PRESS NEWS
Cell Cycle Kinases as Therapeutic Targets for Cancer:
July 3, 2009
A featured article in the July 2009 online issue of Nature Reviews/Drug Discovery written by Antonio Giordano, M.D., Ph.D., DIrector of the Sbarro Institute for Cancer Research and Molecular Medicine, Director of the Center for Biotechnology at Temple University in Philadelphia, PA and ‘Chiara fama’ Professor in the Department of Pathology & Oncology at the University of Siena in Siena, Italy and Silvia Lapenna, Ph.D., a member of CROM (Center for Oncology Research) in Mercogliano, Italy, forecasts that "novel compunds with increased potency, improved kinase specificity and favorable drug like properties will soon be available for clinical evaluation."
Antonio Giordano, M.D., Ph.D. Places Third on List of "Laboratory Heads by Number of Publications"
Cell Cycle Registry: July 2, 2009
Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported: June 29, 2009
A new analysis of breast cancer in Italy from 2000 to 2005 shows a 72 percent spike above official estimates issued by the Ministry of Health, with the sharpest uptick of +28.6 percent found in the youngest group studied (ages 25 to 44). Results from the Sbarro Health Research Organization, the CROM (Centro Richerhe
Oncologiche Mercogliano) in Mercogliano, Italy, and the Human Health Foundation appear in The Journal of Experimental & Clinical Cancer Research.
Breast Cancer News (access by subscription only)
Italy Welcomes New Public Health TV Channel
On February 1st, Italian television introduced a new channel devoted to wellness, disease prevention, and nutrition. Salute!, which appears on Sky Television, is the first channel of its kind in Italy.
Researchers Locate Two New Potential Targets for Pediatric Tumor Treatments
A single tumor-suppressor gene may provide a unique marker for senescence in Mesenchymal stem cells (MSCs) in vitro, while also playing a role in moving MSCs into senescence, researchers at the Human Health Foundation, the Sbarro Institute for Cancer Research and Molecular Medicine, report in Stem Cells and Development. The study represents a joint international effort between the Sbarro Health Research Organization, in Philadelphia, PA, Che University of Siena, in Siena, Italy and Bambin Gesu' in Rome, Italy.
Gene Marker May Improve Odds on Stem Cell Therapies for Disease
Researchers have tagged two new potential targets for treating rhabdomyosarcoma (RMS) -- a highly malignant pediatric tumor thought to arise from mesenchymal stem cells (MSCs) committed to become skeletal muscle cells. The report appears in Cell Cycle.
With an Eye To Italy
Sbarro Health Research Organization President, Antonio Giordano, M.D., featured in Philadelphia Inquirer: With an Eye to Italy: Research scientist builds lab and lures fine minds from home.
|
|
 DONATIONS
All funds raised go to genetic research to help cure and diagnose cancer, cardiovascular disease, diabetes, and HIV-AIDS.
SHRO SITES
SHRO SPONSORS
SHRO EMAIL
Using Office Outlook Web Access Secure Login
|
|
